Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review.

Mia EvansRia GillKim S Bull

Published in: Neuro-oncology advances (2022)

Insufficient evidence means the role of Bevacizumab in the treatment of DIPG is unclear. However, Bevacizumab may be beneficial to some patients. The review highlights the need for further research in this area.

Keyphrases

end stage renal disease
metastatic colorectal cancer
newly diagnosed
ejection fraction
young adults
prognostic factors
low grade
peritoneal dialysis
combination therapy
smoking cessation
patient reported